# Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants

> **NCT01827358** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 155 (actual)

## Conditions studied

- Staphylococcal Infection

## Interventions

- **DRUG:** Mupirocin calcium
- **DRUG:** Mupirocin calcium

## Key facts

- **NCT ID:** NCT01827358
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-30
- **Primary completion:** 2016-06-07
- **Final completion:** 2016-06-21
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827358, "Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01827358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*